Skip to main content
Canna~Fangled Abstracts

Use of cannabidiol (CBD) for the treatment of chronic pain

By September 14, 2020October 3rd, 2020No Comments
Review

doi: 10.1016/j.bpa.2020.06.004. Epub 2020 Jul 2.

Affiliations

Abstract

Chronic pain can be recurrent or constant pain that lasts for longer than 3 months and can result in disability, suffering, and a physical disturbance. Related to the complex nature of chronic pain, treatments have a pharmacological and non-pharmacological approach. Due to the opioid epidemic, alternative therapies have been introduced, and components of the plant Cannabis Sativa, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have gained recent interest as a choice of treatment. The exact mechanism for CBD is currently unknown, but unlike the CBD’s psychoactive counterpart, THC, the side effects of CBD itself have been shown to be overall much more benign. The current pharmaceutical products for the treatment of chronic pain are known as nabiximols, and they contain a ratio of THC combined with CBD, which has been promising. This review focuses on the treatment efficacy of CBD, THC: CBD-based treatments for chronic pain and adverse events with each.

 

Keywords: cannabidiol, chronic pain, nabiximols

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest to disclose.

Publication types

Leave a Reply